Results 201 to 210 of about 3,766,251 (261)
Clinical trial barriers in neurostimulation for pediatric drug‐resistant epilepsy
Abstract Objective The NeuroPace responsive neurostimulation (RNS) System effectively treats focal drug‐resistant epilepsy (DRE) in adults but lacks pediatric regulatory approval. Despite effective off‐label pediatric use, systemic device‐trial challenges have impeded label expansion.
Mira C. Hasner +15 more
wiley +1 more source
Perils and progress in epilepsy surgery utilization: Twenty‐five years later
Abstract More than 25 years have passed since the first randomized controlled trial (RCT) established that surgery is superior to continued anti‐seizure medication (ASM) for drug‐resistant temporal lobe epilepsy, and nearly as long since a joint practice parameter urged that appropriate surgical candidates be referred to a specialized center for ...
Dario J. Englot
wiley +1 more source
Monthly or menstrual? A scoping review of catamenial epilepsy and non‐menstrual seizure rhythms
Abstract Objective Despite the reported high prevalence of catamenial epilepsy (CE), the condition remains poorly defined, with lack of consensus on what entails a menstrual‐related seizure exacerbation. Emerging evidence of multiday cycles of seizure activity, including about‐monthly cycles, present in both men and women, further confound the ...
Victoria Wong +4 more
wiley +1 more source
Abstract Objective This study was undertaken to evaluate seizure outcomes after magnetic resonance‐guided laser interstitial thermal therapy (MRgLITT) in children with insular epilepsy and to assess how the extent of ablation overlaps with multimodal definitions of the ictal onset zone (IOZ).
Lelio Guida +15 more
wiley +1 more source
Abstract Objective To evaluate the comparative cost‐effectiveness of anterior temporal lobectomy (ATL) and magnetic resonance–guided laser interstitial thermal therapy (LITT) in patients with drug‐resistant mesial temporal lobe epilepsy (mTLE). Methods A decision‐analytic model was constructed to simulate the risks, benefits, and costs of ATL versus ...
Zhihao Guo +4 more
wiley +1 more source
Abstract Objective To synthesize evidence on clinical outcomes, direct surgical costs, and cost‐effectiveness of resective epilepsy surgery for drug‐resistant epilepsy in low‐ and middle‐income countries (LMICs). Methods MEDLINE, PubMed, Scopus, and the Cochrane Library were searched through May 17, 2026.
Muhamad Thohar Arifin +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Outcomes in perioperative care
Current Opinion in Anaesthesiology, 2010The present review examines the trends and controversies on how perioperative care can influence outcome after anesthesia and surgery.Recent studies indicate that anesthesia and perioperative care may have a major impact on long-term postoperative mortality and major complications in surgical patients by decreasing the rate of individual decisions. The
Jean, Mantz +2 more
openaire +2 more sources
Measuring perioperative outcome
Current Opinion in Anaesthesiology, 2016Measuring clinically relevant and patient-centered perioperative outcomes provides the knowledge that enables clinicians to optimize their practice and guide shared decision-making, researchers to set a future agenda and policymakers to prioritize healthcare spending.A large international collaboration is currently working to define a set of core ...
Mark, Shulman, Paul, Myles
openaire +2 more sources
Regional anaesthesia and perioperative outcome
Current Opinion in Anaesthesiology, 2006The ongoing debate on the outcome benefits of regional anaesthesia and analgesia over general anaesthesia and systemic analgesia has led to a large number of recently published papers, in particular systematic reviews and meta-analyses that justify a review of the current status of the debate.Meta-analyses have shown consistently improved analgesia ...
Evangelos, Tziavrangos, Stephan A, Schug
openaire +2 more sources
Perioperative outcome in sarcoma surgery
Langenbeck's Archives of Surgery, 2006Soft tissue sarcomas (STS) are rare tumors accounting for less than 1% of all malignancies. Although disease-specific surgical management is increasingly important, only few data are available for STS. Here, we analyze a single institution setting focusing on perioperative surgical and clinical parameters.Prospectively gathered data of all adult ...
Moritz N, Wente +8 more
openaire +2 more sources

